Amanote Research
Register
Sign In
Combination of Chidamide With Choep Regimen in Previously Untreated Patients With Peripheral T-Cell Lymphoma: A Prospective, Multicenter, Single-Arm, Phase 1b/2 Trial
Hematological Oncology
- United Kingdom
doi 10.1002/hon.90_2630
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Hematology
Date
June 1, 2019
Authors
D. Zhou
W. Zhang
L. Su
L. Liu
Y. Gao
Q. Wang
H. Su
Y. Song
H. Zhang
J. Shen
H. Jing
S. Wang
X. Cen
H. Liu
A. Liu
Z. Li
J. Luo
J. He
J. Wang
Publisher
Wiley
Related search
A Phase II Trial of Bendamustine in Combination With Rituximab in Older Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
British Journal of Haematology
Hematology
Sakk 35/15: A Phase I Trial of Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Correction To: Multicenter Phase 1/2 Study of Forodesine in Patients With Relapsed Peripheral T Cell Lymphoma
Annals of Hematology
Medicine
Hematology
Chidamide in the Treatment of Peripheral T-Cell Lymphoma
OncoTargets and Therapy
Oncology
Pharmacology
Combination of Ibrutinib With Rituximab (Ir) Is Highly Effective in Previously Untreated Elderly (>65 Years) Patients (Pts) With Mantle Cell Lymphoma (Mcl) - Phase Ii Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Sintilimab for Relapsed/Refractory (R/R) Extranodal Nk/T Cell Lymphoma (Enktl): A Multicenter, Single-Arm, Phase 2 Trial (Orient-4)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Randomized Phase Ii Study of Chop vs. Fractionated Iced in Transplant-Eligible Patients With Previously Untreated Peripheral T-Cell Lymphoma: Interim Results of Cisl1504
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase 1/1b Dose-Escalation Trial Evaluating Cpi-818, an Oral Interleukin-2-Inducible T-Cell Kinase Inhibitor, in Patients With Relapsed/Refractory T-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Pembrolizumab With Rchop in Previously Untreated Diffuse Large B-Cell and Grade 3b Follicular Lymphoma: Final Results of a Phase I Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology